Clinical Trial

PRO STRESS Trial: Proactive Low-Dose Norepinephrine to Reduce Intraoperative Fluid Administration in Patients at High-Risk for Postoperative Pulmonary Complications Undergoing Laparoscopic Abdominal Surgery

Study acronym: PRO STRESS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Intraoperative hypotension is commonly treated with fluid administration; however, excessive fluid therapy may contribute to postoperative pulmonary complications. This randomized double-blind controlled trial evaluates whether proactive administration of fixed low-dose norepinephrine reduces intraoperative crystalloid administration while maintaining hemodynamic stability in high-risk patients undergoing laparoscopic abdominal surgery. One hundred and thirty patients will be randomized to receive either norepinephrine infusion (0.03 µg/kg/min) or placebo from induction until skin closure within a protocolized hemodynamic strategy guided by mean arterial pressure and pulse pressure variation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-31.
Trial Details
NCT Number NCT07627360
Lead Sponsor Suez Canal University
Conditions Intraoperative Hypotension, Postoperative Pulmonary Complications (PPCs), Fluid Over-load
Enrollment 130 participants
Start Date 2026-07-15
Primary Completion 2026-10 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-13